Your browser doesn't support javascript.
loading
Tanshinone IIA reverses gefitinib resistance in EGFR-mutant lung cancer via inhibition of SREBP1-mediated lipogenesis.
Zhang, Lei; Xu, Chuncao; Huang, Junyuan; Jiang, Shiqin; Qin, Zhiyan; Cao, Lin; Tan, Guoyao; Zhao, Zhongxiang; Huang, Min; Jin, Jing.
Affiliation
  • Zhang L; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Xu C; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Huang J; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Jiang S; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Qin Z; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Cao L; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Tan G; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Zhao Z; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Huang M; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Jin J; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Phytother Res ; 38(3): 1574-1588, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38282115

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Abietanes / Lung Neoplasms Type of study: Prognostic_studies Language: En Journal: Phytother Res Year: 2024 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Abietanes / Lung Neoplasms Type of study: Prognostic_studies Language: En Journal: Phytother Res Year: 2024 Type: Article Affiliation country: China